AIDX20/20 Biolabs, Inc.$0.21Nov 13 close+0.7%1M-34.5%6M-85.1%

Overview Financials Earnings Peers Projection Compare

Loading company

Every figure taken straight from a company’s own SEC filings, with the checks behind each grade shown — and whatever could not be found named rather than hidden.

Appearance

Product

Screener
Earnings calendar
Watchlists
Portfolios

Browse

Rankings
Free this week
Industries
Curated lists
Fund managers

Company

About
How the grade works
Glossary
Pricing
Contact

Legal

Terms of service
Privacy policy
Disclaimer
Cookie policy

InspectStocks describes businesses using their own reported figures. It is not investment advice and does not recommend buying or selling anything.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

20/20 Biolabs, Inc. (AIDX) latest earnings — what was reported — InspectStocks

AIDX20/20 Biolabs, Inc.$0.21Nov 13 close+0.7%1M-34.5%6M-85.1%

Compare

Overview Financials Earnings Peers Projection Compare

20/20 Biolabs, Inc.

AIDX · Nasdaq · Healthcare · Medical Devices

Grade FNot growing

Compare

$0.21+0.7%Nov 13 close

Reported results on November 13, 2026; they are not in these figures yet.

Figures through June 30, 2026, from the 10-Q filed August 14, 2026

Past performance

1W: +4.5%
1M: -34.5%
3M: -62.6%
6M: -85.1%

What 20/20 Biolabs, Inc. reported on August 17, 2026

From the company’s own 8-K filing.

How the share price reacted

Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.

Close before

$0.55

Aug 14, 2026

Close after

$0.52

Aug 18, 2026

Move

-5.99%

230.33K shares traded, against a normal 116.46K

The quote and the company description come from 20/20 Biolabs, Inc.’s Item 2.02 8-K filed August 17, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.

Earnings calls

New

The latest call

Fetching

20/20 Biolabs, Inc. reported on November 13, 2026. We are fetching the call transcript; its summary follows once the transcript is in.